Brian Elliott
Impact in
-
- Lymphoma Diagnosis and Treatment
- Oncology top 5%
- CAR-T cell therapy research
Papers in
- Oncology 14
- CAR-T cell therapy research 13
- Cancer Immunotherapy and Biomarkers 2
-
- Platelet Disorders and Treatments 3
- Co-authors
- Roberto S Oliveri (4 shared papers)Dena DeMarco (5 shared papers)Martin Hutchings (4 shared papers)David John Lewis (3 shared papers)Michael Roost Clausen (6 shared papers)David Cunningham (3 shared papers)Pieternella Johanna Lugtenburg (4 shared papers)Kim Linton (5 shared papers)
- Journals
- Blood (6 papers)HemaSphere (2 papers)ClinicoEconomics and Outcomes Research (2 papers)American Journal of Hematology (1 paper)European Journal Of Haematology (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Brian Elliott
24 papers receiving 958 citations
Brian Elliott's Hit Papers
Peers
Comparison fields: 5 of 50
- Pathology and Forensic Medicine 484
- Oncology 667
- Genetics 131
- Radiology, Nuclear Medicine and Imaging 189
- Hematology 87
Countries citing papers authored by Brian Elliott
This map shows the geographic impact of Brian Elliott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Elliott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Elliott more than expected).
Fields of papers citing papers by Brian Elliott
This network shows the impact of papers produced by Brian Elliott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Elliott. The network helps show where Brian Elliott may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian Elliott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial Hit paper breakdown → | 2022 | 425 |
| 2 | Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study Hit paper breakdown → | 2021 | 258 |
| 3 | Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study Hit paper breakdown → | 2024 | 99 |
| 4 | 2020 | 48 | |
| 5 | 2011 | 33 | |
| 6 | 2022 | 27 | |
| 7 | 2003 | 22 | |
| 8 | 2013 | 14 | |
| 9 | 2006 | 11 | |
| 10 | 2010 | 11 | |
| 11 | 2024 | 10 | |
| 12 | 2018 | 9 | |
| 13 | 2018 | 7 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2016 | 2 | |
| 19 | 2017 | 1 | |
| 20 | 2023 | 1 |
About Brian Elliott
Brian Elliott is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 25 papers that have together received 994 indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Lymphoma Diagnosis and Treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Biosimilars and Bioanalytical Methods (4 papers), Platelet Disorders and Treatments (3 papers), Immunotherapy and Immune Responses (2 papers), Virus-based gene therapy research (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (484 citations), Oncology (667 citations), Genetics (131 citations), Radiology, Nuclear Medicine and Imaging (189 citations) and Hematology (87 citations). Brian Elliott has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Roberto S Oliveri, Dena DeMarco, Martin Hutchings, David John Lewis, Michael Roost Clausen, David Cunningham, Pieternella Johanna Lugtenburg, Kim Linton, Martine E.D. Chamuleau and Peter Johnson. Their work appears in journals such as Blood, HemaSphere, ClinicoEconomics and Outcomes Research, American Journal of Hematology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.